BusinessInsys’s scheme to deceive insurance companies detailed By Maria Cramer — Boston GlobeFeb. 22, 2019 Reprints Insys Therapeutics founder John Kapoor in 2017. Ross D. Franklin/AP Insys’s scheme to deceive insurance companies detailed About the Author Reprints Maria Cramer — Boston Globe
Business Bob Herman STAT Plus: Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the stakes
Pharmalot Ed Silverman and Damian Garde STAT Plus: Shortage of monkeys for early-stage research jeopardizes timelines for developing some drugs
Special Report Brittany Trang STAT Plus: As AI promises to revolutionize medical note-taking, concerns mount about accuracy and harm
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
